Tue.Nov 28, 2023

article thumbnail

Time-dependent differences in vancomycin sensitivity of macrophages underlie vancomycin-induced acute kidney injury [Toxicology]

ASPET

Although vancomycin (VCM)-frequently used to treat drug-resistant bacterial infections-often induces acute kidney injury (AKI), discontinuation of the drug is the only effective treatment; therefore, analysis of effective avoidance methods is urgently needed. Here, we report the differences in the induction of AKI by VCM in 1/2-nephrectomized mice depending on the time of administration.

Therapies 100
article thumbnail

Pharma benefited from basing business overseas. An international tax effort could spur a rethink.

BioPharma Drive: Drug Pricing

U.S. tax law changes enacted six years ago slashed large pharma companies' rates and saved them billions. Now, a push for an international floor could disrupt their R&D accounting.

article thumbnail

Early Promise for Stem Cell Therapy to Curb MS

Drugs.com

TUESDAY, Nov. 28, 2023 -- Stem cells injected into the brains of multiple sclerosis patients appear to protect them against further damage from the degenerative disease, a new study shows.MS occurs when the body’s own immune system attacks and.

Therapies 119
article thumbnail

FDA investigating cancer risk linked to CAR-T cell therapy

BioPharma Drive: Drug Pricing

The agency said the benefit of approved treatments like Gilead’s Yescarta still outweighs any such risk, but the alert could slow drugmaker efforts to develop the treatments for wider use.

Therapies 117
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Internet Poses No Threat to Mental Health, Major Study Finds

Drugs.com

TUESDAY, Nov. 28, 2023 -- It might seem that surfing the web could cause a person’s mental health to suffer, but a landmark new study has concluded that internet use poses no major threat to people’s psychological well-being.Researchers.

111
111
article thumbnail

Solar activity likely to peak next year

Science Daily: Pharmacology News

Researchers have discovered a new relationship between the Sun's magnetic field and its sunspot cycle, that can help predict when the peak in solar activity will occur. Their work indicates that the maximum intensity of solar cycle 25, the ongoing sunspot cycle, is imminent and likely to occur within a year.

Research 109

More Trending

article thumbnail

SQL Server Space Monitoring

Perficient: Drug Development

On Operational projects that involves heavy data volume load on a daily basis, there’s a need to monitor the DB Disk Space availability. Over a period of time, the size grows occupying the disk space. While there are best practices to handle the size by adopting strategies of Purge for outdated data and add buffer/temp/data/log space to address the growing needs, it is necessary to be aware of the Disk space and consistently monitor for further actions.

105
105
article thumbnail

New COVID Variant Takes Hold in the United States

Drugs.com

TUESDAY, Nov. 28, 2023 (Healthday News) -- The prevalence of a highly mutated COVID variant has tripled in the past two weeks, new government data shows.Now, nearly 1 in 10 new COVID cases are fueled by the BA.2.86 variant, the U.S. Centers for.

article thumbnail

What if Alexa or Siri sounded more like you? Study says you'll like it better

Science Daily: Pharmacology News

One voice does not fit all when it comes to virtual assistants like Siri and Alexa, according to researchers who examined how customization and perceived similarity between user and voice assistant (VA) personalities affect user experience. They found a strong preference for extroverted VAs -- those that speak louder, faster and in a lower pitch. They also found that increasing personality similarity by automatically matching user and VA voice profiles encouraged users to resist persuasive infor

article thumbnail

Black Patients Wait Longer Than Whites for Alzheimer's Diagnosis

Drugs.com

TUESDAY, Nov. 28, 2023 — Medical imaging for thinking and memory issues happens much later in Black patients than in their white and Hispanic counterparts, new research shows.A study to be presented Thursday at a meeting of radiologists also.

Research 109
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

How shifting climates may have shaped early elephants' trunks

Science Daily: Pharmacology News

Researchers have provided new insights into how ancestral elephants developed their dextrous trunks. A study of the evolution of longirostrine gomphotheres, an ancestor of the modern day elephant, suggests moving into open-land grazing helped develop their coiling and grasping trunks.

article thumbnail

Could a 'Brain Coach' Help Folks at Higher Risk for Alzheimer's?

Drugs.com

TUESDAY, Nov. 28, 2023 -- Personal trainers can help people increase their strength and their fitness.Could a “brain coach” be just as useful in preventing Alzheimer’s’ disease?A new study suggests that personalized health and lifestyle.

Disease 110
article thumbnail

LSU Health Shreveport chooses Digital Science to support research discovery and integrity

SCIENMAG: Medicine & Health

Digital Science, a technology company serving stakeholders across the research ecosystem, is pleased to announce that Louisiana State University Health Shreveport (LSUHS) has chosen Dimensions Analytics and Dimensions Research Security from Digital Science’s flagship products to advance its world-class research programs.

Science 91
article thumbnail

COVID Vaccines Curbed Pandemic-Linked Surge in Preemie Births

Drugs.com

TUESDAY, Nov. 28, 2023 -- COVID vaccines saved the lives and health of countless babies by preventing their premature births, a new study shows.COVID-19 initially caused an alarming surge in premature birth rates, but those returned to pre-pandemic.

Vaccine 86
article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

Anti-aging effects of 1,5-anhydro-D-fructose on brain diseases via AMPK activation

SCIENMAG: Medicine & Health

A new research paper was published in Aging (listed by MEDLINE/PubMed as “Aging (Albany NY)” and “Aging-US” by Web of Science) Volume 15, Issue 21, entitled, “1,5-anhydro-D-fructose induces anti-aging effects on aging-associated brain diseases by increasing 5’-adenosine monophosphate-activated protein kinase activity via the peroxisome proliferator-activated receptor-γ co-activator-1α/brain-derived neurotrophic factor pathway.

Disease 89
article thumbnail

Darkest Before Dawn: A Story Of Biotech Optimism In A Tough Market

LifeSciVC

By Jeb Keiper, CEO of Nimbus Therapeutics, as part of the From The Trenches feature of LifeSciVC. @JebKeiper Earlier this year, Nimbus closed the sale of our allosteric TYK2 program, which was acquired by Takeda for $4 billion upfront. To say 2023 has been an excellent year for Nimbus would be an understatement and by some standards, the best of our 14-year history (more here ).

article thumbnail

Understanding rapid tendon regeneration in newts may one day help human athletes

SCIENMAG: Medicine & Health

A research group led by Nagoya University’s Graduate School of Engineering has uncovered how rapid tendon regeneration occurs in newts. The research, published in the Journal of Orthopaedic Research, compared the regeneration mechanism of damaged tendons in newts with those in mice.

article thumbnail

How do you make a robot smarter? Program it to know what it doesn't know

Science Daily: Pharmacology News

Engineers have come up with a new way to teach robots to know when they don't know. The technique involves quantifying the fuzziness of human language and using that measurement to tell robots when to ask for further directions. Telling a robot to pick up a bowl from a table with only one bowl is fairly clear. But telling a robot to pick up a bowl when there are five bowls on the table generates a much higher degree of uncertainty -- and triggers the robot to ask for clarification.

article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

article thumbnail

Researchers advance ‘placenta-on-a-chip’ with sensing, imaging technology

SCIENMAG: Medicine & Health

AMES, Iowa – A research poster dated Dec. 9, 2015, hangs just outside Nicole Hashemi’s Iowa State University laboratory. It introduces a major project for Hashemi and her research group. And it’s evidence that scientific persistence sometimes equals scientific advancement. Credit: Photo by Christopher Gannon/Iowa State University. AMES, Iowa – A research poster dated Dec.

article thumbnail

Drug Channels News Roundup, November 2023: My $0.02 on Express Scripts’ Cost-Based Pricing, Mark Cuban vs. PBMs, Dual-WAC Strategies, Pharmacy Shakeout, and Adam vs. Rocky

Drug Channels

I hope everyone enjoyed the Thanksgiving holiday. Now that you’ve stretched your stomach, it's time to stretch your mind with some food for thought. In this issue: A reality check on Express Scripts’ purported “cost-based” pharmacy network Mark Cuban explains how and why the PBM market will change Why two drug prices are better than one Pharmacists sing the retail pharmacy shakeout blues Plus, two Philly legends meet at a cardiology conference!

article thumbnail

Two biomedical sciences researchers named among world’s most highly cited scientists for 2023

SCIENMAG: Medicine & Health

ATLANTA — Two leading researchers in the Institute for Biomedical Sciences at Georgia State University have been ranked in the top 1 percent worldwide by citations for their field and publication year in the Web of Science database, according to the Highly Cited Researchers 2023 list by Clarivate.

Science 85
article thumbnail

Composition of asteroid Phaethon

Science Daily: Pharmacology News

Asteroid Phaethon, which is five kilometers in diameter, has been puzzling researchers for a long time. A comet-like tail is visible for a few days when the asteroid passes closest to the Sun during its orbit. However, the tails of comets are usually formed by vaporizing ice and carbon dioxide, which cannot explain this tail. The tail should be visible at Jupiter's distance from the Sun.

article thumbnail

UTHealth Houston School of Dentistry researcher awarded $2 million grant by NIH to study pharmacotoxicity of areca nut

SCIENMAG: Medicine & Health

A five-year, $2 million grant to study the pharmacological effects of the areca nut, commonly known as the betel nut, was awarded to a UTHealth Houston researcher by the National Institute on Drug Abuse, part of the National Institutes of Health (NIH).

article thumbnail

Roivant’s Matt Gline on raising capital and biotech’s outlook in 2024

BioPharma Drive: Drug Pricing

Fresh off a $7 billion deal with Roche, the chief executive spoke with BioPharma Dive about this year’s “discordant combination” of major biotech achievements alongside market headwinds.

article thumbnail

Understanding subjective beliefs could be vital to tailoring more effective treatments for depression and ADHD

Science Daily: Pharmacology News

Taking into account whether people believe they are receiving a real treatment or a fake one (placebo) could provide better insights that could help improve interventions for conditions such as depression and ADHD.

article thumbnail

EVs and the Evolution of Automotive Commerce: Highlights from Our Detroit Event

Perficient: Drug Development

At the beautiful Shinola Hotel in downtown Detroit, we invited a distinguished group of automotive and mobility industry leaders to participate in a discussion on the current state of the industry. The conversation was lively, and we traded ideas, theories, and suggestions on how OEMs and automotive suppliers could thrive in this changing industry. The two main topics we covered in an hour-long conversation were electric vehicles and the evolving commerce landscape in automotive.

article thumbnail

Antarctic glacier retreating rapidly

Science Daily: Pharmacology News

Scientists are warning that apparently stable glaciers in the Antarctic can 'switch very rapidly' and lose large quantities of ice as a result of warmer oceans. Their finding comes after glaciologists used satellites to track the Cadman Glacier, which drains into Beascochea Bay, on the west Antarctic peninsula.

75
article thumbnail

Testosterone Therapy for Transgender Patients May Be Safer Than Thought

Drugs.com

TUESDAY, Nov. 28, 2023 -- Transgender people transitioning to male (transmasculine) identity typically take testosterone therapy as part of the process. There have been worries that the treatment might spur erythrocytosis, an abnormally high.

article thumbnail

First multi-chamber heart organoids unravel human heart development and disease

Science Daily: Pharmacology News

Heart disease kills 18 million people each year, but the development of new therapies faces a bottleneck: no physiological model of the entire human heart exists -- so far. A new multi-chamber organoid that mirrors the heart's intricate structure enables scientists to advance screening platforms for drug development, toxicology studies, and understanding heart development.

Disease 65
article thumbnail

Smoking Tobacco Plus Weed Greatly Raises Odds for Emphysema

Drugs.com

TUESDAY, Nov. 28, 2023 -- Folks who smoke weed along with cigarettes are doing serious damage to their lungs, a new study warns.People who do both are 12 times more likely to develop emphysema than nonsmokers, due to the damage they’re doing to.

64
article thumbnail

FDA Stealthily Convenes Multi-Cancer Testing Panel Meeting

FDA Law Blog: Biosimilars

By Allyson B. Mullen & Jeffrey N. Gibbs — Shortly before the Thanksgiving holiday, FDA announced with no fanfare that it would be holding a Molecular and Clinical Genetics Panel meeting this Wednesday November 29. The notice ( here ) indicates that FDA plans for the panel to “discuss and make recommendations on the design of multi-cancer detection (MCD) in vitro diagnostic devices (tests) as well as potential study designs and study outcomes of interest that could inform the assessment of t

FDA 62
article thumbnail

PCORI approves $225 million in funding for dozens of health research studies and related projects

SCIENMAG: Medicine & Health

WASHINGTON, D.C. – The Patient-Centered Outcomes Research Institute (PCORI) today announced the approval of funding awards totaling $225 million, which include $207 million to support 20 new patient-centered comparative clinical effectiveness research (CER) studies.

article thumbnail

Which pharmaceutical companies have the most drug patents in Canada?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most patents in Canada. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is… The post Which pharmaceutical companies have the most drug patents in Canada? appeared first on DrugPatentWatch - Make Better Decisions.